Archive - February 2019
Common Myths About Cancer Debunked
Analysts look beyond Keytruda in Merck’s future
Havas Lynx Group scoops nine Golds at PM Society Awards
Pfizer closes on EU approval of lung cancer drug Vizimpro
UK patient activist group takes aim at Orkambi patent
FDA rejects Alkermes’ depressive disorder drug
Migraine treatment Ajovy among CHMP’s six endorsed medicines
Forxiga receives positive EU CHMP for type I diabetes in adults